drugset / Trial / NCT00026533
Thalidomide in Treating Patients With Thyroid Cancer
Treatment
Summary
RATIONALE: Thalidomide may stop the growth of thyroid cancer by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness thalidomide in treating patients who have thyroid cancer.
Timeline
- Start
- 2001-06
- Primary completion
- 2003-11
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thalidomide | Other / unclassified | — | Oral |